SCHEMBL765590

SCHEMBL765590

OCc1ccc(-c2nc(C(Cl)(Cl)Cl)nc(C(Cl)(Cl)Cl)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
MAP2K4 P45985 1/20 0.36
S1PR1 P21453 5/20 0.35
S1PR3 Q99500 1/20 0.35
PIK3CA P42336 4/20 0.35
PIK3CG P48736 3/20 0.35
MTOR P42345 3/20 0.35
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
NOTUM Q6P988 1/20 0.34
KIF11 P52732 1/20 0.34
PIK3CD O00329 1/20 0.34
RIPK1 Q13546 1/20 0.33
PDE7A Q13946 1/20 0.33
PDE7B Q9NP56 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5019508 0.98 MKNK1 (0.40) ADORA3ADORA2AADORA1MKNK1MKNK2
SCHEMBL11973820 0.91 HDAC2 (0.41) ADORA3ADORA2AADORA1MKNK1MKNK2
SCHEMBL8412982 0.84 NPC1 (0.38) ADORA3ADORA2AADORA1TSHR
SCHEMBL2760438 0.81 IDO1 (0.39) PDE7APDE7B
SCHEMBL2832962 0.81 TP53 (0.43) S1PR1
SCHEMBL3343534 0.80 TP53 (0.42) S1PR1
SCHEMBL15316343 0.80 PRKCI (0.47) ADORA3ADORA2AADORA1MAP2K4S1PR1
SCHEMBL14138137 0.80 ABCC4 (0.49) TSHR
SCHEMBL14040238 0.79 S1PR1 (0.39) ADORA3S1PR1S1PR3
SCHEMBL3311317 0.79 L3MBTL1 (0.42) PDE7APDE7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287179-A1 HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME NISSAN CHEMICAL CORPORATION (JP) 2023-09-14 US disclosed
US-9926422-B2 Bump-forming material, method for producing electronic component, method for producing semiconductor device, and semiconductor device FUJITSU LIMITED (JP) 2018-03-27 US disclosed
US-20170260348-A1 BUMP-FORMING MATERIAL, METHOD FOR PRODUCING ELECTRONIC COMPONENT, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJITSU LIMITED (JP) 2017-09-14 US disclosed
US-9470977-B2 Composition for lithographic printing plate and lithographic printing plate precursor EASTMAN KODAK COMPANY (US) 2016-10-18 US disclosed
US-9428606-B2 Polyfunctional epoxy compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-08-30 US disclosed
US-9416289-B2 Active-energy-ray-curable inkjet ink composition, active-energy-ray-curable inkjet ink, and inkjet recording method Konica Minolta, Inc. (JP) 2016-08-16 US disclosed
US-20150353684-A1 HIGHLY SOLUBLE TRIS- (2, 3-EPOXYPROPYL)- ISOCYANURATE AND METHOD FOR PRODUCING SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-12-10 US disclosed
US-9186878-B2 Process for making lithographic printing plate FUJIFILM CORPORATION (JP) 2015-11-17 US disclosed
US-9144964-B2 Process for making lithographic printing plate FUJIFILM CORPORATION (JP) 2015-09-29 US disclosed
US-9140989-B2 Photosensitive organic particles NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-09-22 US disclosed
US-20070144384-A1 Image recording method FUJI PHOTO FILM CO., LTD (JP) 2007-06-28 US disclosed
US-7232205-B2 Capping member, cleaning member, piping member, ink tank member, and UV curable ink jet recording apparatus fitted with the above members KONICA MINOLTA HOLDINGS, INC. (JP) 2007-06-19 US disclosed
US-7220530-B2 Light sensitive planographic printing plate material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-22 US disclosed
US-7217743-B2 Curable white ink KONICA CORPORATION (JP) 2007-05-15 US disclosed
US-7204588-B2 Ink jet printed matter KONICA CORPORATION (JP) 2007-04-17 US disclosed
US-7182453-B2 Ink jet recording apparatus and ink jet recording method KONICA MINOLTA HOLDINGS, INC. (JP) 2007-02-27 US disclosed
US-20070039500-A1 Manufacturing method of lithographic printing plate and manufacturing apparatus of lithographic printing plate FUJI PHOTO FILM CO., LTD. (JP) 2007-02-22 US disclosed
US-7169446-B2 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-01-30 US disclosed
US-7168802-B2 Ink composition and a method for ink jet recording KONICA CORPORATION (JP) 2007-01-30 US disclosed
US-7163970-B2 Actinic ray curable ink and printed matter utilizing the same KONICA MINOLTA HOLDINGS, INC. (JP) 2007-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287179-A1 HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME TTPA, USP1, USP2 ADORA3 4629/4885ADORA2A 4357/4885ADORA1 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.